We are thrilled to announce that FluIDect has successfully secured an FTI-Thüringen TECHNOLOGIE funding grant (Project 2024 FEE 0013) for our latest R&D project! 🎉
This funding will drive the development of our groundbreaking FluorescentResonatorSignature (FRS) technology. Our project will explore biosensor applications in antibiotic resistance research. The goal? A rapid, point-of-care diagnostic solution for carbapenemase-based antibiotic resistance—helping to combat antimicrobial resistance (AMR) globally. 🌍
We’re incredibly proud of our team’s hard work and grateful for the support from our investors and research partners. This milestone brings us closer to bringing cutting-edge biosensor technology to the market.
